Literature DB >> 8280195

Corticosteroid therapy does not prevent nephritis in Henoch-Schönlein purpura.

F T Saulsbury1.   

Abstract

Nephritis occurs in 20%-50% of children with Henoch-Schönlein purpura (HSP), and the onset of renal involvement may be delayed for weeks or months in a substantial proportion of patients. The present study was performed to determine whether corticosteroid therapy was effective in preventing delayed nephritis in children with HSP. The medical records of 69 children with HSP were reviewed. Nineteen patients had acute nephritis occurring from 1-12 days after the onset of other signs and symptoms. The remaining 50 patients had no evidence of acute renal involvement. Of these 50 patients, 20 were treated during the acute phase of the illness with corticosteroids, while 30 never received corticosteroid therapy. Delayed nephritis (> 3 weeks following an initial normal urinalysis) occurred in 4 of 20 (20%) patients who received prior corticosteroid treatment, and in 6 of 30 (20%) patients who were not treated. These results indicate that early corticosteroid therapy does not prevent delayed nephritis in children with HSP.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8280195     DOI: 10.1007/bf00861574

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  14 in total

1.  Long term renal prognosis of Henoch-Schönlein purpura in an unselected childhood population.

Authors:  M Stewart; J M Savage; B Bell; B McCord
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

2.  Anaphylactoid purpura nephritis in childhood: natural history and immunopathology.

Authors:  M Levy; M Broyer; A Arsan; D Levy-Bentolila; R Habib
Journal:  Adv Nephrol Necker Hosp       Date:  1976

3.  Steroid effects on the course of abdominal pain in children with Henoch-Schonlein purpura.

Authors:  N D Rosenblum; H S Winter
Journal:  Pediatrics       Date:  1987-06       Impact factor: 7.124

4.  Schönlein-Henoch nephritis.

Authors:  S R Meadow; E F Glasgow; R H White; M W Moncrieff; J S Cameron; C S Ogg
Journal:  Q J Med       Date:  1972-07

Review 5.  Therapeutics. XV. The management of Henoch-Schonlein purpura.

Authors:  H Ashton; E Frenk; C J Stevenson
Journal:  Br J Dermatol       Date:  1971-08       Impact factor: 9.302

6.  Incidence of renal complications in Schönlein-Henoch purpura syndrome in dependence of an early administration of steroids.

Authors:  J Buchanec; V Galanda; S Beláková; M Minárik; M Zibolen
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

7.  Henoch-Schönlein nephritis: long-term prognosis of unselected patients.

Authors:  O Koskimies; S Mir; J Rapola; J Vilska
Journal:  Arch Dis Child       Date:  1981-06       Impact factor: 3.791

8.  The Schönlein-Henoch syndrome (anaphylactoid purpura).

Authors:  D GAIRDNER
Journal:  Q J Med       Date:  1948-04

Review 9.  Henoch-Schönlein nephritis: prognostic features and the challenge of therapy.

Authors:  H A Austin; J E Balow
Journal:  Am J Kidney Dis       Date:  1983-03       Impact factor: 8.860

10.  Prognostic significance of the glomerular changes in Henoch-Schoenlein nephritis.

Authors:  N Yoshikawa; R H White; A H Cameron
Journal:  Clin Nephrol       Date:  1981-11       Impact factor: 0.975

View more
  15 in total

Review 1.  Henoch-Schönlein purpura.

Authors:  E J Tizard
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

2.  Early treatment with oral immunosuppressants in severe proteinuric purpura nephritis.

Authors:  Salvatore Li Volti; Giovanni Li Volti
Journal:  Pediatr Nephrol       Date:  2003-09-12       Impact factor: 3.714

Review 3.  Treatment-based literature of Henoch-Schönlein purpura nephritis in childhood.

Authors:  Marco Zaffanello; Vassilios Fanos
Journal:  Pediatr Nephrol       Date:  2008-12-09       Impact factor: 3.714

4.  Corticosteroid therapy in Henoch-Schönlein purpura.

Authors:  W Lane; M Robson; A K Leung
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

5.  Corticosteroid therapy does not prevent nephritis in Henoch-Schönlein purpura.

Authors:  F Mollica; S Li Volti; R Garozzo; G Russo
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

6.  Henoch-Schönlein purpura in children: Use of corticosteroids for prevention and treatment of renal disease.

Authors:  Amir Gohari; Douglas G Matsell; Cherry Mammen; Ran D Goldman
Journal:  Can Fam Physician       Date:  2020-12       Impact factor: 3.275

7.  Intravenous dexamethasone followed by oral prednisolone versus oral prednisolone in the treatment of childhood Henoch-Schönlein purpura.

Authors:  Jae Il Shin; Su Jin Lee; Jae Seung Lee; Kee Hyuck Kim
Journal:  Rheumatol Int       Date:  2010-05-13       Impact factor: 2.631

8.  Corticosteroids may improve clinical outcomes during hospitalization for Henoch-Schönlein purpura.

Authors:  Pamela F Weiss; Andrew J Klink; Russell Localio; Matt Hall; Kari Hexem; Jon M Burnham; Ron Keren; Chris Feudtner
Journal:  Pediatrics       Date:  2010-09-20       Impact factor: 7.124

Review 9.  Effects of corticosteroid on Henoch-Schönlein purpura: a systematic review.

Authors:  Pamela F Weiss; James A Feinstein; Xianqun Luan; Jon M Burnham; Chris Feudtner
Journal:  Pediatrics       Date:  2007-11       Impact factor: 7.124

10.  Mycophenolate mofetil plus prednisone for inducing remission of Henoch-Schönlein purpura nephritis: a retrospective study.

Authors:  Fei Han; Liang-liang Chen; Ping-ping Ren; Jing-yun Le; Pei-jing Choong; Hong-ju Wang; Ying Xu; Jiang-hua Chen
Journal:  J Zhejiang Univ Sci B       Date:  2015-09       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.